These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30457960)

  • 41. New psychoactive substance use as a survival strategy in rural marginalised communities in Hungary.
    Csák R; Szécsi J; Kassai S; Márványkövi F; Rácz J
    Int J Drug Policy; 2020 Nov; 85():102639. PubMed ID: 31911024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.
    Wilson CD; Hiranita T; Fantegrossi WE
    Drug Alcohol Depend; 2022 Jul; 236():109468. PubMed ID: 35643039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones.
    Patrick ME; O'Malley PM; Kloska DD; Schulenberg JE; Johnston LD; Miech RA; Bachman JG
    Drug Alcohol Rev; 2016 Sep; 35(5):586-90. PubMed ID: 26711540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Past-year nonmedical use of prescription drugs among women on probation and parole: A cross-sectional study.
    Hall MT; Ball D; Sears J; Higgins GE; Logan TK; Golder S
    Subst Abus; 2018; 39(3):280-285. PubMed ID: 29452065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review.
    Hobbs M; Kalk NJ; Morrison PD; Stone JM
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1289-1304. PubMed ID: 30454908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rates of Synthetic Cannabinoid Use in Adolescents Admitted to a Treatment Facility.
    Martz G; Tankersley W; Mekala HM; Motiwala H
    Prim Care Companion CNS Disord; 2018 Sep; 20(5):. PubMed ID: 30216711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California.
    Wagner KD; Armenta RF; Roth AM; Maxwell JC; Cuevas-Mota J; Garfein RS
    Drug Alcohol Depend; 2014 Aug; 141():99-106. PubMed ID: 24916748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins.
    Banister SD; Connor M
    Handb Exp Pharmacol; 2018; 252():165-190. PubMed ID: 29980914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act.
    Craft S; Dunn M; Vidler D; Officer J; Blagbrough IS; Pudney CR; Henderson G; Abouzeid A; Dargan PI; Eddleston M; Cooper J; Hill SL; Roper C; Freeman TP; Thomas SHL
    Addiction; 2022 Nov; 117(11):2899-2906. PubMed ID: 35665553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre.
    Robson H; Braund R; Glass M; Ashton J; Tatley M
    Clin Toxicol (Phila); 2021 Jun; 59(6):472-479. PubMed ID: 33156704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists.
    Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M
    Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market.
    Norman C; Walker G; McKirdy B; McDonald C; Fletcher D; Antonides LH; Sutcliffe OB; Nic Daéid N; McKenzie C
    Drug Test Anal; 2020 Apr; 12(4):538-554. PubMed ID: 31944624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Naloxone distribution and possession following a large-scale naloxone programme.
    Madah-Amiri D; Gjersing L; Clausen T
    Addiction; 2019 Jan; 114(1):92-100. PubMed ID: 30129078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using clinical and criminal involvement factors to explain homelessness among clients of a psychiatric probation and parole service.
    Solomon P; Draine J
    Psychiatr Q; 1999; 70(1):75-87. PubMed ID: 9924734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Synthetic Cannabinoid Receptor Agonist-Associated Psychotic Disorder: A Case Report].
    Sönmez İ; Köşger F
    Turk Psikiyatri Derg; 2016; 27(1):63-6. PubMed ID: 27369687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of, and Factors Associated With, Illicit Pharmaceutical Opioid Analgesic Use in a Prospective Cohort of People Who Inject Drugs in Melbourne, Australia.
    Horyniak D; Agius PA; Degenhardt L; Reddel S; Higgs P; Aitken C; Stoové M; Dietze P
    Subst Use Misuse; 2015; 50(13):1650-9. PubMed ID: 26576630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United States.
    Palamar JJ; Griffin-Tomas M; Kamboukos D
    Am J Drug Alcohol Abuse; 2015; 41(4):323-31. PubMed ID: 26115351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Motivations, substance use and other correlates amongst property and violent offenders who regularly inject drugs.
    Sutherland R; Sindicich N; Barrett E; Whittaker E; Peacock A; Hickey S; Burns L
    Addict Behav; 2015 Jun; 45():207-13. PubMed ID: 25705014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California.
    Lambdin BH; Kral AH; Comfort M; Lopez AM; Lorvick J
    Addict Sci Clin Pract; 2017 Jun; 12(1):13. PubMed ID: 28610602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid Receptor Agonists: From Horizon Scanning to Notification.
    Hill SL; Dunn M; Cano C; Harnor SJ; Hardcastle IR; Grundlingh J; Dargan PI; Wood DM; Tucker S; Bartram T; Thomas SHL
    Clin Chem; 2018 Feb; 64(2):346-354. PubMed ID: 29038156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.